A Commitment to Immunology
-
CIC Receives $1,200,000 to Launch an Initiative supporting research studying the human immune system in disease
The Beirne B. Carter Center for Immunology Research (CIC) is thrilled to announce that it has received a $1,200,000 gift from the Beirne Carter Foundation (BCF). The Foundation’s latest commitment will help translate new discoveries of how the immune system … Read More
-
Loren Erickson, PhD, Featured in Immunology Explained
Resident Member Loren Erickson, PhD, wrote a blog post for the American Association of Immunologists’ Immunology Explained series. In his article, Erickson describes his research on Alpha-gal syndrome, an allergy that can be initiated by a bite from the lone … Read More
-
Melanie Rutkowski, PhD, featured in Research in Motion
Resident member Melanie Rutkowski, PhD, was featured in this week’s Research in Motion video! “We are hoping to catalyze our discoveries into paradigm-shifting immune therapies, not only for cancer patients, but also other diseases in which the microbiome is dysregulated.”
-
Member Update: Anny Zhou, PhD
Anny Zhou, PhD, Drash Professor of Medicine in the Division of Pulmonary & Critical Care, Department of Medicine, Department of Genome Science and Director of UVA’s Translational Genomic Center, was recently invited to join the CIC’s membership. Zhou joined UVA … Read More
-
Melanie Rutkowski, PhD, Wins Victoria’s Secret Award to Study Ovarian Cancer
CIC resident member Melanie Rutkowski, PhD, was awarded the 2025 Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Grant. The award, in partnership with Pelotonia and the American Association for Cancer Research, funds innovative research projects in breast and … Read More
-
CIC Hosts 2025 Thomas Braciale Lecture
On Monday, October 27, the Beirne B. Carter Center for Immunology Research (CIC) hosted the third annual Thomas Braciale Lecture. This year’s speaker, Christopher Klebanoff, MD, presented a talk titled “Immunogenicity and Therapeutic Targeting of Recurrently Mutated ‘Public’ Neoantigens”, wherein … Read More
